Pharmafile.com’s weekly COVID-19 news round-up
pharmafile | April 15, 2020 | News story | Research and Development |Â Â COVID-19, chloroquine, coronavirus, hydroxychloroquineÂ
Hydroxychloroquine dominates the latest coronavirus news this week. The anti-malaria drug, touted by President Trump as an effective COVID-19 treatment, has proved dangerous in a clinical trial in Brazil. Since Trump has praised the drug there has been an increase in misuse across the US. Critics have also alleged the President’s continuous messaging about the treatment is motivated by his small financial link to Sanofi.
1. Critics say Trump pushing hydroxychloroquine due to his financial ties to manufacturers – Published on 08/04/2020
Critics are arguing that President Donald Trump is touting the malaria drug hydroxychloroquine as a COVID-19 treatment because he has financial links to manufacturers of the drug.
2. US reports increase in Hydroxychloroquine misuse – Published 09/04/2020
The American Association of Poison Control Centers (AAPCC) has said there has been an increase in people abusing the anti-malaria drug hydroxychloroquine, after being touted by President Donald Trump as a coronavirus treatment.
3. Fatal heart complications halt Brazilian study of chloroquine in treating COVID-19 – Published 14/04/2020
A chloroquine study investigating its effects in treating the COVID-19 coronavirus in Brazil has been postponed for safety reasons.
4. Gilead’s promising COVID-19 drug remdesivir shows benefit in 68% of hospitalised patients – Published 14/04/20
Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of its antiviral therapy remdesivir, one of the most promising treatments for patients hospitalised by COVID-19.
5. US to review its funding of the World Health Organization – Published 15/04/20
President Donald Trump has announced the US may stop funding the World Health Organization due to allegations that they covered up the spread of the pandemic.
Related Content
COVID-19 vaccine eligibility creates challenges for UK pharmacies
Pharmacists across England have reported widespread confusion among patients attempting to book COVID-19 vaccination appointments …
Mental health medicine use in England reaches record high, NHSBSA report reveals
According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions …
FDA approves Moderna’s Spikevax for children at increased risk of COVID-19
Moderna has been granted US Food and Drug Administration (FDA) approval for its COVID-19 vaccine, …
